New oral anticoagulants are used increasingly as a first-line treatment for non-valvular atrial fibrillation stroke prevention due to its good efficiency and safety.However,these new oral anticoagulants are expensive and are inappropriate for pregnant women,children,or patients with valvular heart disease or severe renal insufficiency.Therefore,most patients still need to use Warfarin for treatment.Warfarin is recommended for use in the prevention and cure of systemic thrombosis,stroke,and venous thromboemb...
| 
推荐 
点击下列相关研究机构和相关文献作者，可以直接查到这些机构和作者被《中国知识资源总库》收录的其它文献，使您全面了解该机构和该作者的研究动态和历史。
